Mulpleta (lusutrombopag) Coverage
Customize your policy alerts
Sign up for all UnitedHealthcare policy alerts
Know when UnitedHealthcare releases new policies or updates existing guidance.
Monitor payer policy activity
This policy governs prior authorization and medical-necessity coverage for Mulpleta (lusutrombopag) in adults with thrombocytopenia associated with chronic liver disease who are scheduled to undergo a procedure. Approval requires specified clinical criteria, including failure, contraindication, or intolerance to Doptelet (avatrombopag).
The annual review reported no change to the coverage criteria and updated the reference information.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.